SRC and systemic sclerosis: The subsequent identification of anti-Th/To antibodies anchored the diagnosis within the systemic-sclerosis spectrum: anti-Th/To are uncommon overall (~3–6% of SSc) and are enriched in limited cutaneous SSc, often with minimal skin thickening and a propensity for pulmonary involvement and renal complication, including SRC (4).